260 related articles for article (PubMed ID: 1681492)
1. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
[TBL] [Abstract][Full Text] [Related]
2. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
3. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
4. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
5. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
6. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
[TBL] [Abstract][Full Text] [Related]
8. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
9. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of genetic alterations and progression of primary breast cancer.
Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.
Millikin D; Meese E; Vogelstein B; Witkowski C; Trent J
Cancer Res; 1991 Oct; 51(20):5449-53. PubMed ID: 1680551
[TBL] [Abstract][Full Text] [Related]
14. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.
Devilee P; van Vliet M; Bardoel A; Kievits T; Kuipers-Dijkshoorn N; Pearson PL; Cornelisse CJ
Cancer Res; 1991 Feb; 51(3):1020-5. PubMed ID: 1670997
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
Noviello C; Courjal F; Theillet C
Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
18. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
Cornelis RS; Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Kersenmaeker A; Bardoel A; Khan PM; Cornelisse CJ
Oncogene; 1993 Mar; 8(3):781-5. PubMed ID: 8437862
[TBL] [Abstract][Full Text] [Related]
19. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
